Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

    Get Diamond plan for FREE

    logo

    Cue Health Inc. (HLTH)

    Price:

    0.04 USD

    ( - -0.02 USD)

    Your position:

    0 USD

    ACTION PANEL
    CREATE A NOTE
    ABOUT
    Symbol
    HLTH
    Name
    Cue Health Inc.
    Industry
    Medical - Healthcare Information Services
    Sector
    Healthcare
    Price
    0.043
    Market Cap
    6.905M
    Enterprise value
    -8.907M
    Currency
    USD
    Ceo
    Clint Sever
    Full Time Employees
    726
    Ipo Date
    2021-09-24
    City
    San Diego
    Address
    4980 Carroll Canyon Road

    Check the

    KEY TAKEAWAYS

    ASK OUR AI ABOUT THE COMPANY (REGISTER FOR EARLY ACCESS)
    Descriptive alt text

    (REGISTER FOR EARLY ACCESS) CHOOSE A PROMPT ABOVE TO ASK OUR AI ABOUT THE SPECIFIC INFORMATION

    SIMILAR COMPANIES STI SCORE

    Similar STI Score

    GE HealthCare Technologies Inc.

    VALUE SCORE:

    0

    Symbol
    GEHCV
    Market Cap
    25.464B
    Industry
    Medical - Healthcare Information Services
    Sector
    Healthcare

    2nd position

    HealthEquity, Inc.

    VALUE SCORE:

    8

    Symbol
    HQY
    Market Cap
    8.004B
    Industry
    Medical - Healthcare Information Services
    Sector
    Healthcare

    The best

    Progyny, Inc.

    VALUE SCORE:

    9

    Symbol
    PGNY
    Market Cap
    1.770B
    Industry
    Medical - Healthcare Information Services
    Sector
    Healthcare
    FUNDAMENTALS
    P/E
    -0.000
    P/S
    0.000
    P/B
    0.000
    Debt/Equity
    0.192
    EV/FCF
    0.209
    Price to operating cash flow
    -1.000
    Price to free cash flow
    -1.000
    EV/sales
    -0.513
    Earnings yield
    -2.443M
    Debt/assets
    0.141
    FUNDAMENTALS
    Net debt/ebidta
    0.106
    Interest coverage
    -340.684
    Research And Developement To Revenue
    2.345
    Intangile to total assets
    0.058
    Capex to operating cash flow
    -0.144
    Capex to revenue
    0.308
    Capex to depreciation
    0.352
    Return on tangible assets
    -1.167
    Debt to market cap
    301.503k
    Piotroski Score
    3.000
    FUNDAMENTALS
    PEG
    -0.000
    P/CF
    -0.048
    P/FCF
    -0.044
    RoA %
    -109.911
    RoIC %
    -132.174
    Gross Profit Margin %
    -79.163
    Quick Ratio
    2.216
    Current Ratio
    2.539
    Net Profit Margin %
    -526.480
    Net-Net
    0.003
    FUNDAMENTALS PER SHARE
    FCF per share
    -1.031
    Revenue per share
    0.420
    Net income per share
    -2.443
    Operating cash flow per share
    -0.901
    Free cash flow per share
    -1.031
    Cash per share
    0.534
    Book value per share
    1.637
    Tangible book value per share
    1.508
    Shareholders equity per share
    1.637
    Interest debt per share
    0.321
    TECHNICAL
    52 weeks high
    0.740
    52 weeks low
    0.043
    Current trading session High
    0.056
    Current trading session Low
    0.043
    DIVIDEND
    Dividend yield
    0.00%
    Payout ratio
    0.00%
    Years of div. Increase
    0
    Years of div.
    0
    Q-shift
    Dividend per share
    0
    SIMILAR COMPANIES
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Healthcare Information Services
    Dividend yield
    0%
    Payout Ratio
    -1.1044131000000001%
    P/E
    -0.746
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Healthcare Information Services
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.569

    No data to display

    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Healthcare Information Services
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -8.375

    No data to display

    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Healthcare Information Services
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    260.498
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Healthcare Information Services
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.008

    No data to display

    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Healthcare Information Services
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -5.585

    No data to display

    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Healthcare Information Services
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.011

    No data to display

    logo

    Country
    SG
    Sector
    Healthcare
    Industry
    Medical - Healthcare Information Services
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    349.743
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Healthcare Information Services
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -103.755
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Healthcare Information Services
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -1.999
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Healthcare Information Services
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -1.377
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Healthcare Information Services
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    54.745
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Healthcare Information Services
    Dividend yield
    0.0044628037%
    Payout Ratio
    17.669043000000002%
    P/E
    40.509
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Healthcare Information Services
    Dividend yield
    0.039636664%
    Payout Ratio
    62.384963000000006%
    P/E
    15.304
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Healthcare Information Services
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -598.500

    No data to display

    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Healthcare Information Services
    Dividend yield
    0.029802559%
    Payout Ratio
    382.08594%
    P/E
    114.553
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Healthcare Information Services
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -6.682

    No data to display

    DESCRIPTION

    Cue Health Inc., a healthcare technology company, designs and develops diagnostic platform for diagnostic tests for individuals, enterprises, healthcare providers and payors, and public health agencies. The company offers Cue Integrated Care platform comprising hardware and software components, such as Cue Health Monitoring System consisting of Cue Reader, a portable and reusable reader, Cue Cartridge, a single-use test cartridge, and Cue Wand, a sample collection wand; Cue Data and Innovation Layer, a solution with cloud-based data and analytics capability; Cue Virtual Care Delivery Apps, which include Cue Health App and Cue Enterprise Dashboard; and Cue Ecosystem Integrations and Apps, a solution that allows integrations with third-party applications and sensors. It also provides COVID-19 testing kits for the Cue Health Monitoring System The company was formerly known as Cue Inc and changed its name to Cue Health Inc. in December 2017. Cue Health Inc. was incorporated in 2010 and is headquartered in San Diego, California.

    NEWS
    https://images.financialmodelingprep.com/news/verizon-business-returns-to-hlth-2024-to-showcase-how-20241017.jpg
    Verizon Business returns to HLTH 2024 to showcase how 5G innovation drives the future of healthcare

    globenewswire.com

    2024-10-17 09:12:00

    NEW YORK, Oct. 17, 2024 (GLOBE NEWSWIRE) -- Verizon Business returns to the HLTH Event (booth #3028) in Las Vegas to showcase its latest advancements in 5G healthcare solutions. From enhanced connectivity and security to partnership showcases, Verizon Business is at the forefront of empowering healthcare providers with the technology they need to transform patient care.

    https://images.financialmodelingprep.com/news/televox-showcases-latest-patient-relationship-management-innovations-at-hlth-20241016.jpg
    TeleVox Showcases Latest Patient Relationship Management Innovations at HLTH 2024

    globenewswire.com

    2024-10-16 09:00:00

    LAS VEGAS, Oct. 16, 2024 (GLOBE NEWSWIRE) -- TeleVox, the industry-leading provider of omnichannel patient relationship management (PRM) platforms, is showcasing the latest innovations in its suite of payer, pharmaceutical, and enterprise patient engagement solutions at the HLTH annual conference, October 20-23 in Las Vegas. Visitors to TeleVox's booth #4043 will learn about robust features introduced over the past year, from AI-driven SMART SMS to the readmission-reducing Digital Care Programs, and expanded Agent Chat functionality.

    https://images.financialmodelingprep.com/news/unidoc-health-to-attend-hlth-2024-as-part-of-20241002.jpg
    UniDoc Health to Attend HLTH 2024 as Part of S&P500 TelCo's Booth

    prnewswire.com

    2024-10-02 07:30:00

    -- Integrating Advanced eHealth Solutions with the Latest Telecommunications Services VANCOUVER, BC , Oct. 2, 2024 /PRNewswire/ - UniDoc Health Corp. (CSE: UDOC) (FRA: L7T) (OTCQB: UDOCF) ("UniDoc," or the "Company"), an innovator in the eHealth sector, is pleased to announce its participation in the HLTH 2024 conference as part of the booth of one of the largest S&P 500 US-based telecommunications companies ("TelCo"). Key Takeaways: UniDoc Health is showcasing its advanced eHealth platform at HLTH 2024 as part of TelCo's booth.

    https://images.financialmodelingprep.com/news/why-is-cue-health-hlth-stock-up-99-today-20240530.jpg
    Why Is Cue Health (HLTH) Stock Up 99% Today?

    investorplace.com

    2024-05-30 08:04:57

    Cue Health (NASDAQ: HLTH ) stock is up on Thursday despite the healthcare technology company recently announcing plans to wind down its business. Cue Health revealed earlier this week that it's closing up shop with its Chapter 7 bankruptcy relief filing.

    https://images.financialmodelingprep.com/news/why-is-cue-health-hlth-stock-down-40-today-20240529.jpg
    Why Is Cue Health (HLTH) Stock Down 40% Today?

    investorplace.com

    2024-05-29 08:41:09

    Cue Health (NASDAQ: HLTH ) stock is down on Wednesday after the healthcare technology company announced plans to wind down its business. According to a press release from Cue Health, the company has filed voluntary petitions under Chapter 7 of the U.S. Bankruptcy Code to pursue this wind-down.

    https://images.financialmodelingprep.com/news/cue-health-to-pursue-wind-down-of-the-business-20240528.jpg
    Cue Health to Pursue Wind Down of the Business

    businesswire.com

    2024-05-28 16:31:00

    SAN DIEGO--(BUSINESS WIRE)--Cue Health Inc. ("Cue" or the “Company”) (Nasdaq: HLTH), a healthcare technology company, today announced the Company has filed voluntary petitions under Chapter 7 of the U.S. Bankruptcy Code in the District of Delaware to pursue a wind down of its business. Cue has been working diligently to strengthen the Company's financial foundation, including taking a number of actions to reduce costs and improve operational efficiency. Cue also undertook an extensive process t.

    https://images.financialmodelingprep.com/news/why-virios-therapeutics-shares-are-trading-lower-by-around-20240520.jpeg
    Why Virios Therapeutics Shares Are Trading Lower By Around 48%? Here Are Other Stocks Moving In Monday's Mid-Day Session

    http://feeds.benzinga.com

    2024-05-20 13:28:52

    Shares of Virios Therapeutics, Inc. VIRI fell sharply during Monday's session after the company priced a $1.7 million public offering of 8.5 million shares of common stock at $0.20 per share. Virios Therapeutics shares dipped 47.6% to $0.1850 on Monday. Here are some other stocks moving in today’s mid-day session. MultiMetaVerse Holdings Limited MMV shares jumped 224% to $2.01. MultiMetaVerse Holdings signed a non-binding term sheet to acquire 100% of Bowong Technology (Shenzhen) Co., Ltd. and its subsidiaries. GT Biopharma, Inc. GTBP rose 146% to $7.64. GT Biopharma, last week, posted a narrower-than-expected quarterly loss. Tantech Holdings Ltd TANH jumped 89.8% to $1.2501. Faraday Future Intelligent Electric Inc. FFIE shares gained 62.1% to $1.6701. Faraday Future Intelligent Electric is scheduled to report its fourth quarter and full year 2023 results after the closing bell on Tuesday, May 28. CN Energy Group. Inc. CNEY surged 58% to $1.0501. Scorpius Holdings, Inc. SCPX gained 57.8% to $0.1635. Scorpius, last week, announced closing of public offering. NKGen Biotech, Inc. NKGN rose 46% to $1.6250 after the company’s SNK01 NK Cell Therapy was cleared to begin a Phase 2 trial in Alzheimer’s disease. Bruush Oral Care Inc. BRSH jumped 41% to $0.1658. Rekor Systems, Inc. REKR gained 36% to $1.80 after the company announced a partnership with MS2. MIRA Pharmaceuticals, Inc. MIRA gained 34.3% to $0.8866 after the company said it has advanced new preclinical studies using Ketamir-2 towards clinical development. Scilex Holding Company SCLX gained 34% to $1.21. Hims & Hers Health, Inc. HIMS rose 30.5% to $19.01 after the company announced the addition of GLP-1 injections to its weight loss portfolio. BYND Cannasoft Enterprises Inc. BCAN surged 29.5% to $1.4250. Cheetah Mobile Inc. CMCM gained 24.3% to $5.70. Concord Medical Services Holdings Limited CCM jumped 23% to $0.6188. Wix.com Ltd. WIX rose 21.6% to $164.94 as the company posted upbeat results for its first quarter and raised its 2024 forecast on Monday. Sintx Technologies, Inc. SINT shares rose 21.1% to $0.1029 after dipping over 39% on Friday. Sutro Biopharma, Inc. STRO climbed 17.6% to $4.7150. PTC Therapeutics, Inc. PTCT jumped 17.2% to $38.78 after the company announced the European Commission has returned the Translarna opinion to the CHMP for re-evaluation. Cue Health Inc. HLTH gained 17.1% to $0.1128 after dipping around 18% on Friday. Cue Health, last week, announced that it voluntarily and temporarily paused sales and distribution of its EUA COVID-19 Test Cartridge. NextDecade Corporation NEXT climbed 16% to $8.10 after ADNOC announced it secured an equity position and LNG offtake agreement in NextDecade’s Rio Grande LNG project. NuScale Power Corporation SMR rose 15.5% to $7.29. VinFast Auto Ltd. VFS gained 15% to $5.61. Crown ElectroKinetics Corp. CRKN shares rose 14.8% to $0.1964 after falling around 29% on Friday. Tellurian Inc. TELL gained 14% to $0.5870. Shineco, Inc. SISI shares climbed 10.2% to $1.09 after jumping 19% on Friday. Shineco recently announced that its subsidiaries Fuzhou Medashan Biotechnology and Kaifeng Yixi Biotechnology invented a new natural active water-soluble product. Independent Bank Group, Inc. IBTX gained 8.5% to $47.69 after SouthState announced it will acquire the company. Doximity, Inc. DOCS surged 5.1% to $29.46. Akoustis Technologies, Inc. AKTS fell 53.8% to $0.1647 after Qorvo won a jury verdict against the company in a trade secret misappropriation and patent infringement case. Cheetah Net Supply Chain Service Inc. CTNT declined 48% to $5.61. FLJ Group Limited FLJ shares fell 44.5% to $0.86 after surging 224% on Friday. Jaguar Health, Inc JAGX fell 39.8% to $0.1557 after the company announced a 1-for-60 reverse stock split. Fangdd Network Group Ltd. DUO declined 38% to $1.04. Jeffs’ Brands Ltd JFBR shares declined 35.8% to $0.4189 after jumping 109% on Friday. DermTech, Inc. DMTK fell 33.8% to $0.3302. CervoMed Inc. CRVO declined 25.3% to $17.99. CervoMed named William Elder as Chief Financial Officer, effective June 1. Barnes & Noble Education, Inc. BNED dipped 22.6% to $0.3482. Akanda Corp. AKAN shares fell 22.3% to $0.1339 following a 30% surge on Friday. iPower Inc. IPW shares fell 20.8% to $2.29 after jumping 98% on Friday. iPower, last week, reported better-than-expected third-quarter financial results. Nature’s Miracle Holding Inc. NMHI declined 19.9% to $0.5396. Nature’s Miracle mutually agreed to terminate plan to merge with Agrify Corp. Li Auto Inc. LI fell 12.6% to $21.74 after the company reported worse-than-expected first-quarter results and issued second-quarter guidance. GameStop Corp. GME declined 10% to $19.99. Oklo Inc. OKLO fell 8.6% to $8.23. IGM Biosciences, Inc. IGMS declined 8.2% to $8.46. Cemtrex, Inc. CETX shares fell 7.6% to $0.45 after climbing 49% on Friday. Cemtrex, last week, posted a wider quarterly loss. The Beauty Health Company SKIN declined 5.8% to $2.58. Inovio Pharmaceuticals, Inc. INO fell 5.6% to $11.33. ATRenew Inc. RERE shares fell 4.3% to $2.71 after reporting weak quarterly earnings. Now Read This: How To Earn $500 A Month From Lowe’s Stock Ahead Of Q1 Earnings Report © 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

    https://images.financialmodelingprep.com/news/cue-health-evaluating-warning-letter-received-from-food-and-20240513.jpg
    Cue Health Evaluating Warning Letter Received from Food and Drug Administration (FDA)

    businesswire.com

    2024-05-13 20:30:00

    SAN DIEGO--(BUSINESS WIRE)--Cue Health Inc. (Nasdaq: HLTH), a healthcare technology company (the “Company”), has received a warning letter from the FDA about its Emergency Use Authorized (EUA) COVID-19 test. The Company is currently evaluating the letter and determining its response, with more information to follow in the next few days. About Cue Cue Health Inc. (Nasdaq: HLTH) is a healthcare technology company that empowers healthcare providers to streamline their ability to deliver value-base.

    https://images.financialmodelingprep.com/news/cue-health-to-announce-first-quarter-financial-results-20240429.jpg
    Cue Health to Announce First Quarter Financial Results

    businesswire.com

    2024-04-29 16:01:00

    SAN DIEGO--(BUSINESS WIRE)--Cue Health Inc. (“Cue”) (Nasdaq: HLTH), a healthcare technology company, announced today that it will release its first quarter 2024 financial results on Monday, May 13, 2024. The company will not be hosting a conference call. About Cue Health Cue Health Inc. (Nasdaq: HLTH) is a healthcare technology company that uses diagnostic-enabled care to empower people to live their healthiest lives. Cue's platform offers individuals and healthcare providers convenient and per.

    https://images.financialmodelingprep.com/news/cue-health-announces-strategic-actions-to-position-company-for-20240320.jpg
    Cue Health Announces Strategic Actions to Position Company for Next Stage

    businesswire.com

    2024-03-20 17:21:00

    SAN DIEGO--(BUSINESS WIRE)--Cue Health Inc. ("Cue" or the “Company”) (Nasdaq: HLTH), a healthcare technology company, today announced strategic actions implemented by its Board of Directors (the “Board”) to best position the Company for its next stage: Clint Sever, co-founder and current Chief Product Officer, has been appointed CEO, effective immediately. Sever succeeds Ayub Khattak, who is stepping down as Chief Executive Officer, President, and Chairman. Khattak will remain a member of the B.

    https://images.financialmodelingprep.com/news/3-promising-penny-stocks-you-can-pick-up-for-20240318.jpg
    3 Promising Penny Stocks You Can Pick Up for Less Than a Quarter

    investorplace.com

    2024-03-18 20:49:51

    Listen, if you haven't gotten the memo, penny stocks are incredibly dangerous. Yes, they're cheap – in this case, extremely cheap.

    https://images.financialmodelingprep.com/news/cue-health-inc-hlth-q4-2023-earnings-call-transcript-20240313.jpg
    Cue Health, Inc. (HLTH) Q4 2023 Earnings Call Transcript

    seekingalpha.com

    2024-03-13 19:58:08

    Cue Health, Inc. (HLTH) Q4 2023 Earnings Call Transcript

    https://images.financialmodelingprep.com/news/cue-health-inc-hlth-reports-q4-loss-tops-revenue-20240313.jpg
    Cue Health Inc. (HLTH) Reports Q4 Loss, Tops Revenue Estimates

    zacks.com

    2024-03-13 18:10:16

    Cue Health Inc. (HLTH) came out with a quarterly loss of $0.32 per share versus the Zacks Consensus Estimate of a loss of $0.45. This compares to loss of $0.50 per share a year ago.

    https://images.financialmodelingprep.com/news/cue-health-reports-fourth-quarter-2023-financial-results-20240313.jpg
    Cue Health Reports Fourth Quarter 2023 Financial Results

    businesswire.com

    2024-03-13 16:01:00

    SAN DIEGO--(BUSINESS WIRE)--Cue Health Inc. ("Cue" or the “Company”) (Nasdaq: HLTH), a healthcare technology company, today reported financial results for the fourth quarter and full-year 2023. Recent Highlights Reported fourth quarter total revenue of $18.8 million. Full-year 2023 total revenue was $70.9 million Submitted additional clinical samples and stability data for RSV to the FDA in support of de novo submission Submitted additional clinical samples and gathering additional stability da.

    https://images.financialmodelingprep.com/news/cue-health-announces-appointment-of-rishi-reddy-to-board-20240216.jpg
    Cue Health Announces Appointment of Rishi Reddy to Board of Directors

    businesswire.com

    2024-02-16 17:00:00

    SAN DIEGO--(BUSINESS WIRE)--Cue Health (Nasdaq: HLTH), a healthcare technology company, today announced it entered into a cooperation agreement (the “Cooperation Agreement”) with Tarsadia Investments (“Tarsadia”), and appointed Rishi Reddy to its board of directors (the “Board”), effective immediately. Mr. Reddy is a Managing Director at Tarsadia, where he leads the firm's venture and growth equity strategy. He was previously an Observer on Cue's Board of Directors from April 2018 to September.

    https://images.financialmodelingprep.com/news/cue-health-to-participate-at-the-btig-medtech-digital-20240131.jpg
    Cue Health to Participate at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

    businesswire.com

    2024-01-31 16:01:00

    SAN DIEGO--(BUSINESS WIRE)--Cue Health (“Cue”) (Nasdaq: HLTH), a healthcare technology company, announced today that its management team will participate at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference on Tuesday, February 13, 2024. About Cue Health Cue Health Inc. (Nasdaq: HLTH) is a healthcare technology company that uses diagnostic-enabled care to empower people to live their healthiest lives. The Cue Health platform offers individuals and healthcare provid.